Royalty Pharma shares surge 59% after $2.2 billion IPOBiopharma initial public offerings are back with a bang after a coronavirus pandemic lull, as Royalty Pharma raised Share XRoyalty Pharma shares surge 59% after $2.2 billion IPOhttps://pharmaphorum.com/news/royalty-pharma-shares-surge-59-after-2-2-billion-ipo/
Royalty Pharma plans largest IPO of the year so farRoyalty Pharma is planning the biggest IPO of the year as the market’s appetite for biotech stocks remains strong. Share XRoyalty Pharma plans largest IPO of the year so farhttps://pharmaphorum.com/news/royalty-pharma-plans-largest-ipo-of-the-year-so-far/
